Diversity in Clinical Trials and Patient Recruitment Challenges

This document is a report that discusses the critical issue of diversity in clinical trials and the challenges faced in recruiting diverse patient populations. It outlines the significant dropout rates in clinical trials, with an average of 20% of patients not completing their participation and up to 50% of sites failing to recruit enough patients. The report highlights the financial implications of these challenges, noting that 86% of trials do not meet their enrollment deadlines, which increases costs and risks. It emphasizes the importance of having trial populations that reflect the demographics of the disease being studied, as per FDA guidance. The report identifies barriers to enrollment, such as inflexible trial models and the burden of frequent clinic visits on patients. It advocates for a paradigm shift towards decentralized clinical trial designs that utilize technology and community-based approaches to enhance recruitment and retention of diverse populations. The document concludes by stressing the need for a new approach to trial design that prioritizes patient needs and inclusivity.